(MedPage Today) — The FDA approved an allogeneic regulatory T cell-based immunotherapy product with hematopoietic stem and progenitor cells (HSPCs) and T cells (Tregzi) to prevent serious complications of stem cell transplants for hematologic…
Source link : https://www.medpagetoday.com/hematologyoncology/leukemia/122012
Author :
Publish date : 2026-07-01 18:00:00
Copyright for syndicated content belongs to the linked Source.









